Clinical · Preconception
NGS · 2000+ Conditions · Both Partners

Match My Genome

Comprehensive Couple Carrier Screening. Plan Your Family With Confidence.

Every person, on average, carries 6–7 non-working genes that can cause serious genetic disorders — yet most carriers are completely healthy and unaware. When both partners carry a mutation in the same gene, each pregnancy has a 25% chance of an affected child. Match My Genome uses high-resolution Next Generation Sequencing on the Illumina Novaseq 6000 platform to screen both partners simultaneously for carrier status across 2,000+ genetic conditions — giving couples the complete picture they need to plan a healthy family, before conception.

Both partners tested together — This test requires blood samples from both partners. Results are analyzed jointly to identify shared carrier risks. Order includes testing for both individuals.
5.0 (Verified clinical test) NABL & CAP lab
Sample type
Blood + Saliva (Both)
Turnaround
3–4 weeks
Conditions
2,000+
Coverage
150–180X NGS

Conditions screened (2,000+ total)
Beta Thalassemia
Sickle Cell Anemia
Cystic Fibrosis
Spinal Muscular Atrophy
Duchenne Muscular Dystrophy
Fragile X Syndrome
G6PD Deficiency
Hemophilia A & B
Congenital Adrenal Hyperplasia
Hunter Syndrome
X-Linked Mental Retardation
+ 2,000 more conditions

How carrier risk works for your child
When both parents are carriers of the same condition:
AA
Normal
25%
Aa
Carrier (×2)
50%
aa
Affected
25%
Each pregnancy has a 25% chance of an affected child, 50% chance of a carrier child, and 25% chance of a completely unaffected child. Match My Genome identifies this risk before conception — when you have the most options.

What you'll discover

Joint carrier status

Individual carrier status for both partners analyzed together — identifying shared risks that matter for your children

2,000+ conditions

Compatibility report

Clear at-risk conditions where both partners carry mutations in the same gene — exactly what matters for family planning

Shared risk focus

Reproductive options

If at-risk conditions are found — guidance on PGD during IVF, prenatal testing, natural conception monitoring

Informed planning

SNV + CNV analysis

Both single nucleotide variants and copy number variations analyzed — comprehensive mutation detection

Full variant types

De novo vs inherited

Distinguishes between new spontaneous mutations and inherited variants — critical for understanding recurrence risk

Mutation origin

ACOG/ACMG compliant

Analysis follows international recommendations from ACOG, ACMG, and ICMR — globally recognized standards

International standards

How it works
1

Order for both partners

One order covers both partners. Your home collection kits ship within 24 hours — two sets of EDTA blood tubes and saliva swabs included.

2

Both partners collect samples

Each partner collects 2–4ml EDTA blood + saliva swab at home. Both samples returned together using the prepaid courier labels provided.

3

NGS analysis — Illumina Novaseq 6000

Both partners' samples analyzed simultaneously using Illumina Novaseq 6000 at 150–180X coverage across 2,000+ conditions in our NABL & CAP accredited lab.

4

Joint compatibility analysis

Results from both partners compared against each other — flagging conditions where both carry mutations in the same gene, which is the critical shared risk information.

5

Couple report + Genomic Expert consultation

Comprehensive couple carrier report in 3–4 weeks — including individual carrier status, shared at-risk conditions, and personalized reproductive options. Genomic Expert consultation included.


Sample report preview

Your Match My Genome Report

A snapshot of your couple carrier screening report

Partner 1 Carriers
3 genes
Carrier for 3 conditions
Partner 2 Carriers
2 genes
Carrier for 2 conditions
At-Risk (Shared)
0 genes
No shared risk conditions
Conditions Screened
2,000+
Both partners analyzed
Individual carrier reports
Shared at-risk conditions
SNV + CNV analysis
ACMG variant classification
Reproductive options guide
Clinician-ready PDF report

Frequently asked questions
Who should consider Match My Genome?
Match My Genome is recommended for all couples planning to conceive — regardless of family history. The American College of Obstetricians and Gynecologists (ACOG) recommends carrier screening for all patients either preconception or during pregnancy. It is especially important for consanguineous couples (related individuals), couples from similar ethnic backgrounds with higher genetic disorder prevalence (e.g., South Asian, Ashkenazi Jewish, Mediterranean), couples with a family history of genetic disorders, and those who have experienced recurrent pregnancy loss or previous affected pregnancies.
How is Match My Genome different from individual carrier tests?
Individual carrier tests (like our Beta-Thalassemia or Sickle Cell tests) screen for one specific condition. Match My Genome screens both partners simultaneously for 2,000+ genetic conditions in a single test — and critically, analyzes both results together to identify shared risks. A single partner being a carrier of a condition is generally not a health risk; what matters is when BOTH partners carry mutations in the SAME gene. Match My Genome identifies these shared risks with one comprehensive test.
What happens if a shared at-risk condition is found?
Finding a shared at-risk condition means both partners carry mutations in the same gene, giving each pregnancy a 25% chance of an affected child. Our Genomic Expert will explain the specific condition, its severity, and available options in detail. Reproductive options may include preimplantation genetic diagnosis (PGD) during IVF — selecting unaffected embryos before pregnancy — prenatal diagnosis during pregnancy, natural conception with awareness and monitoring, or adoption. The right option depends on the specific condition and your personal values.
Why is this important even without a family history?
Every person carries approximately 6–7 non-working genes on average — and most carriers have absolutely no family history and no symptoms. These recessive conditions only appear when a child inherits two non-working copies — one from each parent. Since carriers are healthy and have no way of knowing without testing, carrier screening before conception is the only way to identify this invisible risk proactively.
Is data from both partners kept private?
Yes. Each partner's individual genetic data is fully private and protected under ISO 27001, HIPAA, and GDPR standards. Individual data is never shared with the other partner without explicit consent — only the joint compatibility analysis is shared as a couple's report. Neither partner's individual carrier status is accessible to the other unless they choose to discuss it.
MyGenoRoot AI Assistant
Ask anything about our DNA tests
Hi! I can answer your questions about MyGenoRoot's DNA tests — pricing, what's included, how testing works, and more. What would you like to know?
💜 Clinical · Couple Carrier Screening
₹45,000 ₹50,000
You save ₹5,000 — includes both partners
  • 2,000+ genetic conditions screened
  • Both partners tested — one order
  • Illumina Novaseq 6000 · 150–180X coverage
  • SNV + CNV analysis
  • NABL & CAP accredited lab
  • Genomic Expert couple consultation
Samples required from both partners
👤
Partner 1
Blood + Saliva
👤
Partner 2
Blood + Saliva
Couples
1
Secure checkout · SSL encrypted
Free pan-India shipping (2 kits)
Results in 3–4 weeks
Each partner's data stays private
NABL & CAP accredited
Genomic Expert Consultation — Included
After results, our Genomic Expert reviews findings with both partners together and guides next steps including reproductive options if any at-risk conditions are found.
Appointment link sent via email after order confirmation.
NABL & CAP

Accredited lab

2,000+ Conditions

NGS panel

Both Partners

Joint analysis

ISO 27001

Data security

100% Private

Individual data protected

Complete your family planning
People also explore

Complement your carrier screening with these related tests

Next step after Match My Genome
Prenatal
NIPT Plus Microdeletions

Once pregnant, NIPT Plus provides comprehensive prenatal chromosomal screening — the natural next step after preconception carrier screening.

₹25,000
Focused screening
Beta-Thalassemia

High-prevalence carrier condition in South Asia. If Match My Genome identifies Beta-Thal carrier risk, targeted testing confirms the specific HBB mutation.

₹9,000
Diagnostic
Chromosomal MicroArray

If Match My Genome raises concerns, CMA provides high-resolution chromosomal analysis — detecting deletions and duplications beyond carrier gene mutations.

₹15,000

Shipping Details

Where should we deliver your Beta-Thalassemia Screening kit?

Recipient name is required
Enter a valid 10-digit phone number
Address is required
City is required
Select your state
Enter a valid 6-digit pincode